Skip to main content
Have a personal or library account? Click to login
Artificial and biological membranes in acute kidney injury: a biomedical engineering framework on renal replacement therapy in critical care Cover

Artificial and biological membranes in acute kidney injury: a biomedical engineering framework on renal replacement therapy in critical care

Open Access
|Jul 2026

References

  1. Kidney Disease: Improving Global Outcomes Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
  2. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–766. doi:10.1016/S0140-6736(11)61454-2.
  3. Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. doi:10.1007/s00134-015-3934-7.
  4. Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482–1493. doi:10.2215/CJN.00710113.
  5. Cerdá J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial. 2009;22(2):114–122. doi:10.1111/j.1525-139X.2008.00549.x.
  6. Ronco C. Continuous renal replacement therapy: forty-year anniversary. Int J Artif Organs. 2017;40(6):257–264. doi:10.5301/ijao.5000610.
  7. Gagel A, Wiesen G, Stuard S, Canaud B. Advances in membrane, dialyzer design, and related monitoring technologies for hemodiafiltration: translating bench-side innovations to bedside applications. J Clin Med. 2026;15(5):1921. doi:10.3390/jcm15051921.
  8. Perl J, Bargman JM. Peritoneal dialysis: from bench to bedside and bedside to bench. Am J Physiol Renal Physiol. 2016;311(5). doi:10.1152/ajprenal.00012.2016.
  9. Raharjo Y, Abidin MNZ, Ismail AF, et al. Dialysis membranes for acute kidney injury. Membranes (Basel). 2022;12(3):325. doi:10.3390/membranes12030325.
  10. Nalesso F, Garzotto F, Cattarin L, et al. The future for end-stage kidney disease treatment: implantable bioartificial kidney challenge. Appl Sci. 2024;14(2):491. doi:10.3390/app14020491.
  11. Ebefors K, Lassén E, Anandakrishnan N, Azeloglu EU, Daehn IS. Modeling the glomerular filtration barrier and intercellular crosstalk. Front Physiol. 2021;12:689083. doi:10.3389/fphys.2021.689083.
  12. Benzing T, Salant DJ. Insights into glomerular filtration and albuminuria. N Engl J Med. 2021;384(15):1437–1446. doi:10.1056/NEJMra1808786.
  13. Haraldsson B, Nyström J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008;88(2):451–487. doi:10.1152/physrev.00055.2006.
  14. Alamilla-Sánchez ME, Alcala Salgado MA, Ulloa Galván VUU, et al. Understanding renal tubular function: key mechanisms, clinical relevance, and comprehensive urine assessment. Pathophysiology. 2025;32(3):33. doi:10.3390/pathophysiology32030033.
  15. Féraille E, Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev. 2001;81(1):345–418. doi:10.1152/physrev.2001.81.1.345.
  16. Misra M. Basic mechanisms governing solute and fluid transport in hemodialysis. Hemodial Int. 2008;12 Suppl 2. doi:10.1111/j.1542-4758.2008.00320.x.
  17. Devuyst O. Assessing transport across the peritoneal membrane: precision medicine in dialysis. Perit Dial Int. 2021;41(4):349–351. doi:10.1177/08968608211022236.
  18. Melo P, Ramírez-Guerrero G, Castro R, et al. Ultrafiltration in the critically ill patient: a framework for personalized care. Crit Care. 2026;30(1):87. doi:10.1186/s13054-026-05836-x.
  19. Krediet RT. Physiology of peritoneal dialysis: pathophysiology in long-term patients. Front Physiol. 2024;15:1322493. doi:10.3389/fphys.2024.1322493.
  20. Alaqarbeh M. Adsorption phenomena: definition, mechanisms, and adsorption types: short review. Rhazes. 2021;13:43–51. doi:10.48419/imist.prsm/rhazes-v13.28283.
  21. Fabbrini P, Vergani D, Malinverno A, et al. Protein-bound uremic toxins and inflammation process in hemodialysis patients: is there a role for adsorption hemodiafiltration? Blood Purif. 2023;52 Suppl 1(Suppl 1):85–94. doi: 10.1159/000540402. Epub 2024 Jul 24. Erratum in: Blood Purif. 2024;53(11–12):947. doi: 10.1159/000541224.
  22. Chelamcharla M, Leypoldt JK, Cheung AK. Dialyzer membranes as determinants of the adequacy of dialysis. Semin Nephrol. 2005;25(2):81–89. doi:10.1016/j.semnephrol.2004.09.014.
  23. Honoré PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS—a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J. 2013;59(2):99–106. doi:10.1097/MAT.0b013e3182816a75.
  24. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B. MCO membranes: enhanced selectivity in high-flux class. Sci Rep 2015;5:18448. doi:10.1038/srep18448.
  25. Clark WR, Gao D. Low-molecular-weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol. 2002;13 Suppl 1.
  26. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25(26):5681–5703. doi:10.1016/j.biomaterials.2004.01.023.
  27. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int. 1993;13 Suppl 2.
  28. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–479. doi:10.1681/ASN.V132470.
  29. Westphalen H, Saadati S, Bahig J, Doan H, Shoker A, Abdelrasoul A. Impact of dialysis clinical operating conditions on human serum protein-mediated inflammatory biomarkers released in patients using polyarylethersulfone membranes. J Compos Sci. 2022;6(8):226. doi:10.3390/jcs6080226.
  30. Richter RP, Russell RT, Huynh TN, et al. The endothelial glycocalyx in critical illness: a pediatric perspective. Matrix Biol Plus. 2022;14:100106. doi:10.1016/j.mbplus.2022.100106.
  31. Cullis B, Abdelraheem M, Abrahams G, et al. ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults). Perit Dial Int. 2021;41(1):15–31. doi:10.1177/0896860820970834.
  32. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422–427. doi:10.1038/ki.2009.159.
  33. Ding F, Humes HD. The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol. 2008;109(4). doi:10.1159/000142936.
  34. Pino CJ, Humes HD. Stem cell technology for the treatment of acute and chronic renal failure. Transl Res. 2010;156(3):161–168. doi:10.1016/j.trsl.2010.07.005.
DOI: https://doi.org/10.62838/jccm-2026-0038 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 313 - 327
Submitted on: Jul 8, 2026
Accepted on: Jul 12, 2026
Published on: Jul 27, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Mihai Alexandru Maier, Leonard Azamfirei, Dorin Bica, Bianca-Liana Grigorescu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.